These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 24670431)
21. Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010. Head MG; Fitchett JR; Moore DA; Atun R JRSM Open; 2015 Mar; 6(3):2054270415577056. PubMed ID: 25893108 [TBL] [Abstract][Full Text] [Related]
22. Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis. Head MG; Goss S; Gelister Y; Alegana V; Brown RJ; Clarke SC; Fitchett JRA; Atun R; Scott JAG; Newell ML; Padmadas SS; Tatem AJ Lancet Glob Health; 2017 Aug; 5(8):e772-e781. PubMed ID: 28668230 [TBL] [Abstract][Full Text] [Related]
23. Infectious disease research investments follow colonial ties: questionable ethics. Fitchett JR; Head MG; Atun R Int Health; 2014 Mar; 6(1):74-6. PubMed ID: 24464047 [TBL] [Abstract][Full Text] [Related]
24. A systematic analysis of UK cancer research funding by gender of primary investigator. Zhou CD; Head MG; Marshall DC; Gilbert BJ; El-Harasis MA; Raine R; O'Connor H; Atun R; Maruthappu M BMJ Open; 2018 Apr; 8(4):e018625. PubMed ID: 29712689 [TBL] [Abstract][Full Text] [Related]
25. Ebola research funding: a systematic analysis, 1997-2015. Fitchett JR; Lichtman A; Soyode DT; Low A; Villar de Onis J; Head MG; Atun R J Glob Health; 2016 Dec; 6(2):020703. PubMed ID: 27909582 [TBL] [Abstract][Full Text] [Related]
26. Global public and philanthropic investment in childhood cancer research: systematic analysis of research funding, 2008-16. Loucaides EM; Fitchett EJA; Sullivan R; Atun R Lancet Oncol; 2019 Dec; 20(12):e672-e684. PubMed ID: 31797794 [TBL] [Abstract][Full Text] [Related]
27. Use of Bibliometric Analysis to Assess the Scientific Productivity and Impact of the Global Emerging Infections Surveillance and Response System Program, 2006-2012. Reaves EJ; Valle R; Chandrasekera RM; Soto G; Burke RL; Cummings JF; Bausch DG; Kasper MR Mil Med; 2017 May; 182(5):e1749-e1756. PubMed ID: 29087920 [TBL] [Abstract][Full Text] [Related]
28. [Analysis on funds application of community based organizations involved in HIV/AIDS response and government financial investment in China, 2014]. Zhang G; Zhu YX; Wang P; Liu P; Li JF; Sha S; Yang WZ; Li H Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):232-236. PubMed ID: 28260337 [No Abstract] [Full Text] [Related]
29. Global trends in psycho-oncology research investments 2016-2020: A content analysis. Conti I; Davidson M; Cutress RI; McIntosh SA; Head MG Psychooncology; 2024 Jan; 33(1):e6273. PubMed ID: 38141045 [TBL] [Abstract][Full Text] [Related]
30. UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia. Luengo-Fernandez R; Leal J; Gray A BMJ Open; 2015 Apr; 5(4):e006648. PubMed ID: 25869683 [TBL] [Abstract][Full Text] [Related]
31. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis. Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524 [TBL] [Abstract][Full Text] [Related]
32. UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study. Bragginton EC; Piddock LJ Lancet Infect Dis; 2014 Sep; 14(9):857-68. PubMed ID: 25065509 [TBL] [Abstract][Full Text] [Related]
33. Allocation of funding into blast injury-related research and blast traumatic brain injury between 2000 and 2019: analysis of global investments from public and philanthropic funders. Denny JW; Brown RJ; Head MG; Batchelor J; Dickinson AS BMJ Mil Health; 2023 Apr; 169(2):127-132. PubMed ID: 33243763 [TBL] [Abstract][Full Text] [Related]
34. Neglected tropical diseases in Brazil: lack of correlation between disease burden, research funding and output. Fonseca BP; Albuquerque PC; Zicker F Trop Med Int Health; 2020 Nov; 25(11):1373-1384. PubMed ID: 32860446 [TBL] [Abstract][Full Text] [Related]
36. Financing of U.S. biomedical research and new drug approvals across therapeutic areas. Dorsey ER; Thompson JP; Carrasco M; de Roulet J; Vitticore P; Nicholson S; Johnston SC; Holloway RG; Moses H PLoS One; 2009 Sep; 4(9):e7015. PubMed ID: 19750225 [TBL] [Abstract][Full Text] [Related]
37. The 10 largest public and philanthropic funders of health research in the world: what they fund and how they distribute their funds. Viergever RF; Hendriks TC Health Res Policy Syst; 2016 Feb; 14():12. PubMed ID: 26892771 [TBL] [Abstract][Full Text] [Related]
38. Resource allocation for biomedical research: analysis of investments by major funders. Ralaidovy AH; Adam T; Boucher P Health Res Policy Syst; 2020 Feb; 18(1):20. PubMed ID: 32066463 [TBL] [Abstract][Full Text] [Related]
39. Investments in tuberculosis research - what are the gaps? Khan MS; Fletcher H; ; Coker R BMC Med; 2016 Aug; 14(1):123. PubMed ID: 27558175 [TBL] [Abstract][Full Text] [Related]
40. Systematic analysis of global health research funding in Canada, 2000-2016. Hoffman SJ; Gunn E; Rogers Van Katwyk S; Nixon S Can J Public Health; 2020 Feb; 111(1):80-95. PubMed ID: 31696423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]